Development of a nanoemulsion incorporating 3-acetyl-11-keto-β-boswellic acid (AKBA): solubility and oral bioavailability through in vitro and in vivo studies

Key Points

• The study aims to evaluate the enhancement of oral bioavailability of AKBA using a nanoemulsion delivery system.
• Development of a nanoemulsion incorporating AKBA.
• Assessment of solubility and oral bioavailability through in vitro experiments.
• Conducting in vivo studies to analyze the absorption and effectiveness of the nanoemulsion.
• Nanoemulsion significantly increases the oral bioavailability of AKBA.
• Enhanced solubility of AKBA was observed in the nanoemulsion.
• The findings suggest potential for further therapeutic development of AKBA.